SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dishman Carbogen Amcis informs about credit rating

22 Dec 2022 Evaluate
Dishman Carbogen Amcis has informed that India Ratings & Research ('Ind-Ra') has affirmed the Company's Rating for long term credit facilities at 'IND A+', for short term credit facilities at 'IND A1+', and assigned Rating for Proposed non-convertible debentures/term loan at 'IND A+’ with a 'Stable' outlook. Since the company did not proceed with the commercial paper instrument as envisaged, based upon company's request, it has withdrawn Rating for this instrument. Details of instrument wise rating are mentioned in the attached file.

The above information is a part of company’s filings submitted to BSE.

Dishman Carbogen Amc Share Price

168.60 -2.00 (-1.17%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×